Navigation Links
Brain Fitness Predicts Crash Risk
Date:1/15/2010

WASHINGTON, Jan. 15 /PRNewswire/ -- Performance at simple mental tasks is highly predictive of crash risk and a small amount of cognitive training can cut the crash risk of older drivers in half, according to research presented this week at the 2010 annual meeting of the Transportation Research Board of the National Academy of Sciences.

This year, the age wave of 70 million baby boomers begins to join the ranks of some 39 million drivers already over age 65. Over time, older drivers tend to reduce their driving, but they still have a crash rate that is the highest of any age group, other than teenagers. Older drivers have the highest fatality rate from automobile crashes of all age groups. Yet, in our society "hanging up the keys" can be devastating and can lead to higher incidence of illness and death.

Three researchers presented findings that indicate that the crash risk of older drivers can be more accurately predicted, that it can be cut in half, and that older drivers can extend their period of safe driving.

Dr. Sam Chan of Posit Science presented data from a field trial with auto insurer Allstate involving 4,036 policyholders over age 50. It showed that poor performance in brief computerized cognitive tasks (involving speed of processing, useful field of view and divided attention) was highly predictive of the three-year crash history of drivers.

Dr. Karlene Ball of the University of Alabama presented data from a randomized controlled trial of 2,812 people over age 65 showing that a computerized cognitive training program could cut at-fault crash risk in half after just 10 hours of training. The training also improves reaction time, increases stopping distance by 22 feet, and reducing dangerous driving maneuvers.

Dr. Jerri Edwards of the University of South Florida presented data showing that morbidity increases after driving cessation, independent of health condition. She also showed that the cognitive training program reduced driving cessation risk of those trained by 40 percent, allowing them to keep driving safely, longer.

The computerized assessments and exercises were developed and measured over the past decade with funding from the National Institutes of Health. They are now commercially available to the general public for the first time in a software product called DriveSharp.  

DriveSharp is recommended by the AAA Foundation for Traffic Safety. It retails for $89 and is available to AAA members for $79 through AAA clubs. For more information, visit www.DriveSharpNow.com.

Posit Science

Posit Science is the leader in clinically proven brain fitness programs and works with over 50 scientists from prestigious universities to design and test its interactive computer-based programs. More than 60 articles in leading science and medical journals show that the company's patented technologies significantly increase visual processing speed, improve memory and attention and enhance quality of life. Posit Science has received grants from the National Institutes of Health and numerous awards and accolades. The company's products, scientists and science are currently featured in the PBS documentary "Brain Fitness Frontiers." For more information, visit www.PositScience.com or call 1-800-599-6463.

SOURCE Posit Science

RELATED LINKS
http://www.PositScience.com

'/>"/>

SOURCE Posit Science
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Draining away brains toxic protein to stop Alzheimers
2. Vision restoration therapy shown to improve brain activity in brain injured patients
3. Clinical depression linked to abnormal emotional brain circuits
4. Brain imaging reveals breakdown of normal emotional processing
5. Brain cells work differently than previously thought
6. Vaccine Stops Alzheimers Brain Tangles
7. Research may unlock mystery of autisms origin in the brain
8. Scientists Spot Brains Free Will Center
9. Free will takes flight: how our brains respond to an approaching menace
10. Alcoholics With Cirrhosis Have More Brain Damage
11. Brain Lesions Predict MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: